News - epratuzumab

Filter

Current filters:

epratuzumab

Popular Filters

Immunomedics says that adding 90Y-epratuzumab following R-CHOP improves patients' response

11-06-2013

US biopharmaceutical company Immunomedics (Nasdaq: IMMU) reports that adding two doses of epratuzumab…

BiotechnologyepratuzumabImmunomedicsOncologyResearch

UCB and Immunomedics amend epratuzumab accord

29-12-2011

New Jersey, USA-based Immunomedics (Nasdaq: IMMU) and Belgian drugmaker UCB (Euronext Brussels: UCB)…

epratuzumabImmunologicalsImmunomedicsLicensingPharmaceuticalRare diseasesUCB

Back to top